Skip to main content
Fig. 1 | Antimicrobial Resistance & Infection Control

Fig. 1

From: Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin

Fig. 1

Relative changes in gene abundance at 6 and 12 months after treatment with placebo or azithromycin. Changes related to baseline gene abundance of mefA (a, b), ermF (c, d) and ermB (e, f) at 6 and 12 months are shown. Results are visualized in box-plots with median and 10th and 90th percentiles (dots show outliers). The dotted line shows the zero line. Mean logs ratio and statistics are shown in Table 4

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us